Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Agouron Pharmaceuticals)"
Count: 17
Selected: 0
NCT IDTitle
NCT00006326Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
NCT00006211A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
NCT00005002Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005001Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005000Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00004999Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
NCT00004998Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00004985Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy
NCT00002185A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
NCT00002171A Study of Viracept in HIV-Positive Women
NCT00002170A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)
NCT00002169A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
NCT00002165Viracept Expanded Access Program
NCT00002164Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants
NCT00205283Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
NCT00002235A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors
NCT00006441Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV